These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 6268511

  • 21. Effect of paraventricular lesions on corticotropin-releasing factor (CRF)-like immunoreactivity in the stalk-median eminence: studies on the adrenocorticotropin response to ether stress and exogenous CRF.
    Bruhn TO, Plotsky PM, Vale WW.
    Endocrinology; 1984 Jan; 114(1):57-62. PubMed ID: 6317350
    [Abstract] [Full Text] [Related]

  • 22. Corticotrope response to removal of releasing factors and corticosteroids in vivo.
    Dallman MF, Makara GB, Roberts JL, Levin N, Blum M.
    Endocrinology; 1985 Nov; 117(5):2190-7. PubMed ID: 2995008
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Saireito (a Chinese herbal drug)-stimulated secretion and synthesis of pituitary ACTH are mediated by hypothalamic corticotropin-releasing factor.
    Nakano Y, Suda T, Tozawa F, Dobashi I, Sato Y, Ohmori N, Sumitomo T, Demura H.
    Neurosci Lett; 1993 Sep 17; 160(1):93-5. PubMed ID: 8247339
    [Abstract] [Full Text] [Related]

  • 25. ACTH releasing activity of KP-102 (GHRP-2) in rats is mediated mainly by release of CRF.
    Hirotani C, Oki Y, Ukai K, Okuno T, Kurasaki S, Ohyama T, Doi N, Sasaki K, Ase K.
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan 17; 371(1):54-60. PubMed ID: 15645295
    [Abstract] [Full Text] [Related]

  • 26. Vasopressin and CRF-ACTH in adrenalectomized and dexamethasone-treated rats.
    Hashimoto K, Yunoki S, Kageyama J, Ohno N, Takahara J, Ofuji T.
    Neuroendocrinology; 1981 Feb 17; 32(2):87-91. PubMed ID: 6259547
    [Abstract] [Full Text] [Related]

  • 27. Hemorrhage-induced secretion of corticotropin-releasing factor-like immunoreactivity into the rat hypophysial portal circulation and its inhibition by glucocorticoids.
    Plotsky PM, Vale W.
    Endocrinology; 1984 Jan 17; 114(1):164-9. PubMed ID: 6317342
    [Abstract] [Full Text] [Related]

  • 28. Magnocellular axons in passage through the median eminence release vasopressin.
    Holmes MC, Antoni FA, Aguilera G, Catt KJ.
    Nature; 1984 Jan 17; 319(6051):326-9. PubMed ID: 3001538
    [Abstract] [Full Text] [Related]

  • 29. Calmodulin inhibitors decrease the CRF-and AVP-induced ACTH release in vitro: interaction of calcium-calmodulin and the cyclic AMP system.
    Murakami K, Hashimoto K, Ota Z.
    Neuroendocrinology; 1985 Jul 17; 41(1):7-12. PubMed ID: 2991797
    [Abstract] [Full Text] [Related]

  • 30. Effect of angiotensin II, catecholamines and glucocorticoid on corticotropin releasing factor (CRF)-induced ACTH release in pituitary cell cultures.
    Murakami K, Hashimoto K, Ota Z.
    Acta Med Okayama; 1984 Aug 17; 38(4):349-55. PubMed ID: 6093444
    [Abstract] [Full Text] [Related]

  • 31. Regulation of the expression and secretion of urocortin 2 in rat pituitary.
    Nemoto T, Iwasaki-Sekino A, Yamauchi N, Shibasaki T.
    J Endocrinol; 2007 Feb 17; 192(2):443-52. PubMed ID: 17283244
    [Abstract] [Full Text] [Related]

  • 32. Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood.
    Gibbs DM, Vale W.
    Brain Res; 1983 Nov 28; 280(1):176-9. PubMed ID: 6317143
    [Abstract] [Full Text] [Related]

  • 33. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG, Patchev V, Vergalla J, Chrousos G, Jones EA.
    J Clin Invest; 1993 May 28; 91(5):1903-8. PubMed ID: 8387536
    [Abstract] [Full Text] [Related]

  • 34. Specificity of cultured anterior pituitary cells in detecting corticotropin releasing factor(s): the effect of biologically active peptides and neurotransmitter substances on ACTH release in pituitary cell cultures.
    Hashimoto K, Yunoki S, Hosogi H, Takahara J, Ofuji T.
    Acta Med Okayama; 1979 Apr 28; 33(2):81-90. PubMed ID: 38634
    [Abstract] [Full Text] [Related]

  • 35. Role of epinephrine and vasopressin in the control of the pituitary-adrenal response to stress.
    Tilders FJ, Berkenbosch F, Vermes I, Linton EA, Smelik PG.
    Fed Proc; 1985 Jan 28; 44(1 Pt 2):155-60. PubMed ID: 2981737
    [Abstract] [Full Text] [Related]

  • 36. Calcium-dependent control of corticotropin release in rat anterior pituitary cell cultures.
    Abou-Samra AB, Catt KJ, Aguilera G.
    Endocrinology; 1987 Sep 28; 121(3):965-71. PubMed ID: 2441983
    [Abstract] [Full Text] [Related]

  • 37. Decreased ACTH secretion during prolonged transportation stress is associated with reduced pituitary responsiveness to tropic hormone stimulation in cattle.
    Knights M, Smith GW.
    Domest Anim Endocrinol; 2007 Nov 28; 33(4):442-50. PubMed ID: 17029676
    [Abstract] [Full Text] [Related]

  • 38. Corticosteroid inhibition of ACTH secretion.
    Keller-Wood ME, Dallman MF.
    Endocr Rev; 1984 Nov 28; 5(1):1-24. PubMed ID: 6323158
    [Abstract] [Full Text] [Related]

  • 39. Isolated pituitary cells: glucocorticoids do not rapidly suppress ACTH secretion in response to CRF.
    Familari M, Funder JW.
    Am J Physiol; 1989 Jan 28; 256(1 Pt 1):E145-51. PubMed ID: 2463764
    [Abstract] [Full Text] [Related]

  • 40. Hypothalamic peptide regulation of ACTH secretion from sheep pituitary.
    Kemppainen RJ, Clark TP, Sartin JL, Zerbe CA.
    Am J Physiol; 1993 Oct 28; 265(4 Pt 2):R840-5. PubMed ID: 8238455
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.